Clinical Presentation Analysis
The newborn presents with a constellation of findings that are highly concerning for
Early-Onset Sepsis (EOS), defined as a serious bacterial infection occurring within the first
72 hours of life
[2]. The vital signs are markedly abnormal: a heart rate of
180 bpm (tachycardia; normal resting rate is 120-160 bpm), a respiratory rate of
70 breaths/min (tachypnea; normal is 30-60), and a temperature of
97.2°F (36.2°C) (hypothermia, as a normal axillary temperature is 36.5-37.5°C). These objective signs of physiological instability, combined with the subjective findings of poor feeding and lethargy, form a clinical picture that demands immediate investigation for systemic infection. In the context of EOS, the transition from subtle symptoms to critical illness can be rapid and devastating, particularly with pathogens like Group B Streptococcus (GBS) and Escherichia coli .
Priority Assessment and Clinical Reasoning
The most important initial assessment is to
assess for signs of sepsis including blood pressure, capillary refill, and skin color. This choice directly addresses the most life-threatening potential progression of the patient's condition: septic shock. The clinical signs of tachycardia, tachypnea, and hypothermia are not isolated findings; they represent a systemic inflammatory response to infection. This response triggers massive peripheral vasodilation and increased capillary permeability, leading to relative hypovolemia and maldistribution of blood flow. The nurse must immediately evaluate the newborn's hemodynamic stability. Checking blood pressure will identify hypotension, a late and ominous sign of decompensated shock in neonates. Assessing capillary refill provides a direct bedside evaluation of peripheral perfusion; a refill time greater than
3 seconds indicates poor cardiac output and tissue hypoperfusion. Inspecting skin color for pallor, mottling, or cyanosis reveals the body’s compensatory attempt to shunt blood to vital organs. This rapid cardiovascular assessment is the cornerstone of the
Serial Clinical Observation (SCO) strategy, a real-world approach used to monitor at-risk infants and trigger timely antibiotic therapy when clinical signs of sepsis emerge .
Analysis of Incorrect Options
While the other options are important components of a full neonatal assessment, they do not take precedence over evaluating for hemodynamic compromise in an already symptomatic infant.
Checking blood glucose level (Option 2) is a critical intervention because lethargy, poor feeding, and temperature instability are classic signs of hypoglycemia. However, in this scenario, hypoglycemia is more likely a symptom of the underlying septic process rather than the primary diagnosis. The stress of infection dramatically increases metabolic demand, rapidly depleting glucose stores. Treating hypoglycemia without addressing the source of the stress will only provide a temporary solution.
Evaluating neurological reflexes (Option 3) is part of a comprehensive newborn assessment, but it does not address the immediate threat of cardiovascular collapse. Lethargy in this context is a non-specific sign of systemic illness, not necessarily a primary neurological injury.
Measuring oxygen saturation (Option 4) is a standard, non-invasive assessment for respiratory distress. While the tachypnea makes this a logical step, it is not the most critical initial action. The nurse can apply a pulse oximeter simultaneously with the cardiovascular assessment, but the priority is to first determine if the infant is in shock. A normal oxygen saturation reading could provide false reassurance in a patient whose primary problem is poor perfusion and impending organ failure from sepsis. The decision to initiate the sepsis workup and antibiotic therapy is driven by the recognition of these abnormal clinical signs, a process validated in multicenter studies on the early recognition of EOS .
References (research sources)
- [2]
A machine learning model for prediction of early-onset neonatal sepsis in low-income and middle-income countries: development and validation study.Research articleKainth D, Gupta A, Singh P, Prakash S, Thukral A, Deorari A, Kapoor M, Agarwal R, Sethi T, Sankar MJ. (2026) · DOI: 10.1136/bmjpo-2025-003561